During the past decade, Center for Cancer Care and Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 34 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Cancer Care and Research" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Novartis Pharmaceuticals" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ARCA Biopharma, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Cancer Care and Research" #1 collaborator was "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Center for Cancer Care and Research" are "Breast Cancer" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials) and "Stage IIIB Breast Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Center for Cancer Care and Research" in a lesser frequency.

Most popular intervention types in "Center for Cancer Care and Research" are "Drug" (46 trials), "Other" (28 trials), "Biological" (21 trials), "Radiation" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Bevacizumab" (12 trials), "Paclitaxel" (10 trials), "Carboplatin" (8 trials) and "Quality-of-Life Assessment" (8 trials). Other intervention names were less common.

The vast majority of trials in "Center for Cancer Care and Research" are 37 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Cancer Care and Research". undefined are not yet recruiting, undefined are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Center for Cancer Care and Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Cancer Care and Research, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".